2021 Annual Public Meeting

Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration.

Engagement | Innovation | Evidence

May 12, 2021
10:00 AM – Noon (eastern)

Stakeholder engagement, innovation, and the use of real-world evidence are key components in improving America’s public health. Join us for an in-depth conversation on FDA priorities with Acting Commissioner Dr. Janet Woodcock followed by an overview of the FDA Foundation’s programs, partnerships, and impact. This free virtual meeting is open to the public, but advanced registration is required.

Janet Woodcock
Janet Woodcock, MD, Commissioner of Food and Drugs (Acting), U.S. Food and Drug Administration

 

Thank you to those who joined us. Check back soon for meeting highlights.

Agenda

10:00 AM


 

Welcome & Opening Remarks

Ellen V. Sigal, PhD
Board Chair, Reagan-Udall Foundation for the FDA

10:05 AM
 


 

A Conversation with the Acting Commissioner of Food and Drugs

Janet Woodcock, MD
Commissioner of Food and Drugs (Acting)
U.S. Food and Drug Administration

10:25 AM


































 

FDA Foundation: Engagement, Innovation, Evidence

Introduction of panelists and discussion

  • Susan C. Winckler, RPh, Esq., CEO, Reagan-Udall Foundation for the FDA
  • RADM Denise Hinton, Chief Scientist, FDA

IMEDS

  • Adrian Hernandez, MD, MHS, IMEDS Committee Chair, Reagan-Udall Foundation for the FDA
  • Jacqueline Corrigan-Curay, JD, MD, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA 

Evidence Accelerator

  • Susan C. Winckler, RPh, Esq., CEO, Reagan-Udall Foundation for the FDA
  • Gina Valo, White House Presidential Innovation Fellow, FDA

Vaccine Confidence

  • Georges C. Benjamin, MD, Food & Nutrition Committee Chair, Reagan-Udall Foundation for the FDA
  • Lorrie McNeill, Director, Office of Communication Outreach and Development, Center for Drug Evaluation and Research, FDA

Food & Nutrition

  • Sally J. Greenberg, Board Member, Reagan-Udall Foundation for the FDA
  • Robin McKinnon, PhD, MPA, Senior Advisor for Nutrition Policy, Center for Food Safety and Applied Nutrition, FDA

Expanded Access

  • Kay Holcombe, MS, Board Secretary, Reagan-Udall Foundation for the FDA
  • Lori Bickel, JD, Regulatory Counsel, FDA

11:30 AM


 

Public Comment

Open to individuals who have submitted a written request (in advance) to present a three-minute statement.

12:00 PM

Adjourn

View Speaker Bios

 

 

Public Comments

Public comments are strictly limited to three minutes per speaker.

Comments should be submitted to Amara Shomali via email at admin@reaganudall.org by 5 PM eastern on May 10, 2021. The email should include your written comments along with your full name, affiliation, address, telephone number, and email address. You will receive a response to your request by May 11, 2021.